A 64-year-old with T2D and ASCVD is already on GLP‑1 RA. eGFR 48 mL/min/1.73 m² and UACR 220 mg/g. Which additional therapy is recommended to improve ...

Question

A 64-year-old with T2D and ASCVD is already on GLP‑1 RA. eGFR 48 mL/min/1.73 m² and UACR 220 mg/g. Which additional therapy is recommended to improve renal and CV outcomes?

Accepted Answer

Add SGLT2 inhibitor

Answer

Add DPP-4 inhibitor

Answer

Add sulfonylurea

Answer

Stop GLP‑1 RA and switch to insulin

Answer

Add pioglitazone

us-abim MCQ (SBA): Diabetes & CKD-Combination Therapy

A 64-year-old with T2D and ASCVD is already on GLP‑1 RA. eGFR 48 mL/min/1.73 m² and UACR 220 mg/g. Which additional therapy is recommended to improve renal and CV outcomes?